Status:
COMPLETED
Effect of Levodopa-Carbidopa on Visual Function in Patients With Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Conditions:
Nonarteritic Anterior Ischemic Optic Neuropathy
Eligibility:
All Genders
50+ years
Phase:
PHASE4
Brief Summary
Purpose: There are some controversies about the effect of Levodopa-Carbidopa on treatment of non-arteritic anterior ischemic optic neuropathy (NAION). This study was performed to evaluate the effect o...
Eligibility Criteria
Inclusion
- age greater than 50 years old
- first ophthalmic examination within 6 weeks after onset of disease
- presence of optic disc swelling followed by optic atrophy within 6 weeks
- altitudinal, central or generalized visual field defect
- normal ESR
Exclusion
- confirmed giant cell arteritis
- history of any ocular surgeries
- optic neuropathy due to acute bleeding
- advanced diabetic retinopathy
- uncontrolled glaucoma
- any ocular disorders that cause visual acuity reduction rather than NAION
Key Trial Info
Start Date :
June 1 2002
Trial Type :
INTERVENTIONAL
End Date :
April 1 2003
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00432393
Start Date
June 1 2002
End Date
April 1 2003
Last Update
October 20 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophthalmic research center
Tehran, Tehran Province, Iran, 1666694516